Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifosfamide and Radiotherapy in Soft Tissue Sarcoma
NCT01102608Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Mar 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ifosfamide in soft tissue sarcoma (STS), sponsored by Spanish Group for Research on Sarcoma. Primary endpoint: Clinical and Pathological Response at 10 weeks. Started Mar 2008; status: completed.
02
Drugs
ifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01102608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102608.